Published online before print March 20, 2006, doi: 10.1161/CIRCULATIONAHA.105.580167
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:1615-1621.)
© 2006 American Heart Association, Inc.
Vascular Medicine |
VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection)
From Sino-German Laboratory for Molecular Medicine (Y.W., W.Z., C.Z., Y. Zheng, Y. Zhen, K.S., C.F., T.Y., J.W., J.S., R.H.), Hypertension Division (Y. Zhang, H.W., R.H.), Department of Cardiology (Y.Y., J.C., R.H.), and Department of Cardiovascular Surgery (L.S., S.H), Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College and National Genome Center (Beijing); and Division of Basic Medical Sciences (W.C.G.), Mercer University School of Medicine, Macon, Ga.
Reprint requests to Rutai Hui, MD, PhD, Cardiovascular Institute & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 167 Beilishilu, Beijing 100037, People’s Republic of China. E-mail huirutai{at}sglab.org
Received August 1, 2005; revision received January 18, 2006; accepted January 20, 2006.
Background— The haplotypes in the gene vitamin K epoxide reductase complex subunit 1 (VKORC1) have been found to affect warfarin dose response through effects on the formation of reduced-form vitamin K, a cofactor for 
-carboxylation of vitamin K–dependent proteins, which is involved in the coagulation cascade and has a potential impact on atherosclerosis. We hypothesized that VKORC1-dependent effects on the coagulation cascade and atherosclerosis would contribute to susceptibility for vascular diseases.
Methods and Results— To test the hypothesis, we studied the association of polymorphisms of VKORC1 with stroke (1811 patients), coronary heart disease (740 patients), and aortic dissection (253 patients) compared with matched controls (n=1811, 740, and 416, respectively). Five common noncoding single-nucleotide polymorphisms of VKORC1 were identified in a natural haplotype block with strong linkage disequilibrium (D'>0.9, r2>0.9), then single-nucleotide polymorphism (SNP) +2255 in the block was selected for the association study. We found that the presence of the C allele of the +2255 locus conferred almost twice the risk of vascular disease (odds ratio [OR] 1.95, 95% confidence interval [CI] .58 to 2.41, P<0.001 for stroke; OR 1.72, 95% CI 1.24 to 2.38, P<0.01 for coronary heart disease; and OR 1.90, 95% CI 1.04 to 3.48, P<0.05 for aortic dissection). We also observed that subjects with the CC and CT genotypes had lower levels of undercarboxylated osteocalcin (a regulator for the bone), probably vascular calcification, and lower levels of protein induced in vitamin K absence or antagonism II (PIVKA-II, a des--carboxy prothrombin) than those with TT genotypes.
Conclusions— The haplotype of VKORC1 may serve as a novel genetic marker for the risk of stroke, coronary heart disease, and aortic dissection.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  K. Nimptsch, S. Rohrmann, A. Nieters, and J. Linseisen Serum Undercarboxylated Osteocalcin as Biomarker of Vitamin K Intake and Risk of Prostate Cancer: A Nested Case-Control Study in the Heidelberg Cohort of the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Rost, S. M. Greenberg, and J. Rosand The Genetic Architecture of Intracerebral Hemorrhage Stroke, July 1, 2008; 39(7): 2166 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Teichert, L.E. Visser, R.H.N. van Schaik, A. Hofman, A.G. Uitterlinden, P.A.G. M. De Smet, J.C.M. Witteman, and B.H.Ch. Stricker Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism and Aortic Calcification: The Rotterdam Study Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 771 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Song, J. Chen, K. Sun, H. Yu, and R. Hui No Association of PLIN Polymorphisms With Hemorrhagic and Ischemic Stroke Stroke, February 1, 2008; 39(2): 470 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Pearson Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, Y. Zheng, W. Zhang, H. Yu, K. Lou, Y. Zhang, Q. Qin, B. Zhao, Y. Yang, and R. Hui Polymorphisms of KDR Gene Are Associated With Coronary Heart Disease J. Am. Coll. Cardiol., August 21, 2007; 50(8): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sanz, P. R. Moreno, and V. Fuster The Year in Atherothrombosis J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749. [Full Text] [PDF]
|
|
|
|
|
|
M. Dichgans and R. A. Hegele Update on the Genetics of Stroke and Cerebrovascular Disease 2006 Stroke, February 1, 2007; 38(2): 216 - 218. [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Gage, E. Birman-Deych, and M. J. Radford The Association of Warfarin Use With Osteoporotic Fracture in Elderly Patients With Atrial Fibrillation--Reply Arch Intern Med, July 24, 2006; 166(14): 1525 - 1525. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M.H. Spronk Vitamin K Epoxide Reductase Complex and Vascular Calcification: Is This the Important Link Between Vitamin K and the Arterial Vessel Wall? Circulation, March 28, 2006; 113(12): 1550 - 1552. [Full Text] [PDF]
|
|